These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9399032)

  • 41. [Effects of an analogue of angiotensin II, [Sar1,Ile8] ATII, on blood pressure, plasma renin activity and plasma aldosterone in various forms of hypertension].
    Yamamoto I; Kim KS; Miyamori I; Morimoto S; Takeda R
    Nihon Naibunpi Gakkai Zasshi; 1977 Jul; 53(7):910-20. PubMed ID: 913717
    [No Abstract]   [Full Text] [Related]  

  • 42. The role of sympathetic activity in normal renin essential hypertension.
    Eng FW; Huber-Smith M; McCann DS
    Hypertension; 1980; 2(1):14-9. PubMed ID: 6989754
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A clinical study on the role of the renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure.
    Nishioka A; Kubo S; Hirota Y; Kawamura K; Takatsu T
    Jpn Heart J; 1982 Jul; 23(4):527-44. PubMed ID: 6752473
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Borderline hypertensive autosomal dominant polycystic kidney disease patients have enhanced production of renal dopamine. Normalization of renal haemodynamics by DOPA infusion.
    Barendregt JN; Florijn KW; Muizert Y; Chang PC
    Nephrol Dial Transplant; 1995; 10(8):1332-41. PubMed ID: 8538923
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Negative association between plasma aldosterone concentration/plasma renin activity and morning blood pressure surge in never-treated hypertensive patients.
    Cho JS; Ihm SH; Jang SW; Chung WB; Choi YS; Shin DI; Seo SM; Park MW; Kim GH; Her SH; Kim CJ; Kim TH; Kang MK; Chang K; Park CS
    Clin Exp Hypertens; 2014; 36(4):195-9. PubMed ID: 24678899
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypertension, lipid abnormalities and cardiovascular changes in autosomal dominant polycystic kidney disease.
    Polat H; Karayaylali I; Niyazova Z; Seyrek N; Paydaş S; Sagliker Y
    Nephron; 1998; 78(3):369-71. PubMed ID: 9546713
    [No Abstract]   [Full Text] [Related]  

  • 47. [Renin-aldosterone system in secretion of cortisol in patients with arterial hypertension in European North].
    Iakovlev VA; Sokol LIu; Karlov VA
    Klin Med (Mosk); 1998; 76(1):35-7. PubMed ID: 9532913
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of renin-angiotensin-aldosterone system gene polymorphisms and hypertension-induced end-stage renal disease in autosomal dominant polycystic kidney disease.
    Ramanathan G; Elumalai R; Periyasamy S; Lakkakula B
    Iran J Kidney Dis; 2014 Jul; 8(4):265-77. PubMed ID: 25001132
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Sympathetic nervous system and renin-angiotensin-aldosterone system in hypertension].
    Iwanami J; Mogi M; Horiuchi M
    Nihon Rinsho; 2011 Nov; 69(11):1916-9. PubMed ID: 22111308
    [No Abstract]   [Full Text] [Related]  

  • 50. [The physiopathology of dialysis-associated hypertension].
    Cohen EP; Krzesinski JM
    Nephrol Ther; 2007 Oct; 3 Suppl 3():S150-5. PubMed ID: 18340680
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neurogenic factors in low renin essential hypertension.
    Campese VM; Myers MR; DeQuattro V
    Am J Med; 1980 Jul; 69(1):83-91. PubMed ID: 6992576
    [No Abstract]   [Full Text] [Related]  

  • 52. Renin angiotensin system and sympathetic nerve activity in mild essential hypertension. The functional significance of angiotensin II in untreated and thiazide treated hypertensive patients.
    Ibsen H; Leth A; Hollnagel H; Kappelgaard AM; Damkjaer M; Nielsen MD; Christensen NJ; Giese J
    Acta Med Scand Suppl; 1979; 625():97-102. PubMed ID: 285581
    [No Abstract]   [Full Text] [Related]  

  • 53. Studies on catecholamines, renin and aldosterone following Catapresan (2-(2,6-dichlor-phenylamine)-2-imidazoline hydrochloride) in hypertensive patients.
    Hökfelt B; Hedeland H; Dymling JF
    Eur J Pharmacol; 1970; 10(3):389-97. PubMed ID: 5422465
    [No Abstract]   [Full Text] [Related]  

  • 54. Analysis of arterial pressure regulating systems in renal post-transplantation hypertension.
    Grisk O; Heukäufer M; Steinbach A; Gruska S; Rettig R
    J Hypertens; 2004 Jan; 22(1):199-207. PubMed ID: 15106812
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Catecholamines in the blood and the renin-angiotensin-aldosterone axis in essential hypertension].
    Cerasola GA; Morici ML; Andronico G; Picciotto G; Cottone S; Bucalo M
    Boll Soc Ital Cardiol; 1981; 26(12):2279-91. PubMed ID: 6764360
    [No Abstract]   [Full Text] [Related]  

  • 56. [Effects of changes in the sodium balance on plasma catecholamines and renin activity at rest and on their response to orthostatic stimulation in arterial hypertension].
    Morganti A; Pickering T; Lopez-Ovejero J; Laragh J
    Minerva Nefrol; 1981; 28(3):261-4. PubMed ID: 7036014
    [No Abstract]   [Full Text] [Related]  

  • 57. [The renin-angiotensin system and the sympathetic nervous system in essential hypertension].
    Vincent M; Milon H; Revol T; Annat G; Froment A; Sassard J; Cier JF
    Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():91-4. PubMed ID: 6810836
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Systemic Succinate, Hypoxia-Inducible Factor-1 Alpha, and IL-1β Gene Expression in Autosomal Dominant Polycystic Kidney Disease with and without Hypertension.
    Kocyigit I; Taheri S; Eroglu E; Sener EF; Zararsız G; Uzun I; Tufan E; Mehmetbeyoglu E; Korkmaz Bayramov K; Sipahioglu MH; Ozkul Y; Tokgoz B; Oymak O; Axelsson J
    Cardiorenal Med; 2019; 9(6):370-381. PubMed ID: 31319406
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sodium-lithium countertransport in autosomal polycystic kidney disease.
    Li Vecchi M; Andronico G; Ferrara L; Renda F; Parrino IA; Pavone G; Mulé G; Ferrantelli A; Di Natale E; Cerasola G
    Contrib Nephrol; 1997; 122():31-4. PubMed ID: 9399034
    [No Abstract]   [Full Text] [Related]  

  • 60. Hypertension in autosomal dominant polycystic kidney disease.
    Chapman AB; Stepniakowski K; Rahbari-Oskoui F
    Adv Chronic Kidney Dis; 2010 Mar; 17(2):153-63. PubMed ID: 20219618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.